Unicancer R&D publications

2018

Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with ...

X. Liang et al, J Hematol Oncol. 2018 Oct 11;11(1):124. doi: 10.1186/s13045-018-0670-9.

2018

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer.

P. Cottu et al, Ann Oncol. 2018 Dec 1;29(12):2334-2340. doi: 10.1093/annonc/mdy448.

2018

The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, ...

F. Penault-Llorca et al, BMC Cancer. 2018 May 4;18(1):526. doi: 10.1186/s12885-018-4331-8.

2016

Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial

P. J.A.M. Brouwers et al., Radiother Oncol. 2016 Jul;120(1):107-13.

2016

Breast cancer screening: On our way to the future [article in French]

Delaloge S et al., Bull Cancer. 2016 Jul 26.

2016

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Cardoso F et al., N Engl J Med. 2016 Aug 25;375(8):717-29.